Evidence map›Paper›PMID 42253903›Full record

ArticleReproductive medicine and biology

Hyperosmotic HEPES-CZB Enhances Post-ICSI Survival of C57BL/6N Mouse Oocytes.

Kango Yamaji, Rei Inoue, Sayaka Wakayama, Daiyu Ito, Teruhiko Wakayama

Abstract read
In one paragraph

Article in Reproductive medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kango YamajiFaculty of Life and Environmental Science University of Yamanashi Yamanashi Japan.ORCID https://orcid.org/0009-0004-0311-4166
Rei InoueFaculty of Life and Environmental Science University of Yamanashi Yamanashi Japan.
Sayaka WakayamaAdvanced Biotechnology Center University of Yamanashi Yamanashi Japan.
Daiyu ItoFaculty of Life and Environmental Science University of Yamanashi Yamanashi Japan.
Teruhiko WakayamaFaculty of Life and Environmental Science University of Yamanashi Yamanashi Japan.ORCID https://orcid.org/0000-0002-6151-2603

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aimed to determine whether performing intracytoplasmic sperm injection (ICSI) under transiently increased osmolality in HEPES-CZB can improve post-ICSI survival as well as embryo and offspring production in C57BL/6N mice. Methods: HEPES-CZB was supplemented with 0-200 mM NaCl or KCl, or 0-400 mM D(+)-glucose or D(-)-mannitol. Oocytes were transferred to each hyperosmotic medium and then subjected to ICSI. Post-ICSI survival, normal fertilization, and blastocyst development were evaluated as rates per injected oocytes. Blastocyst quality was examined by immunostaining to quantify cell types and numbers. Two-cell embryos generated under the best conditions were transferred to evaluate full-term development. Results: Across supplements, increased osmolality consistently reduced oocyte diameter. Following ICSI, the survival rate of these oocytes was significantly increased, and development to the blastocyst stage was maximized under conditions of 100 mM NaCl, 100 mM KCl, 150 mM glucose, and 200 mM mannitol. Under these conditions, the full-term development per injected oocyte remained comparable to the control. Conclusion: Hyperosmotic ICSI significantly improves post-ICSI survival but may compromise developmental competence at higher concentrations, resulting in no net increase in offspring production. Further optimization may increase the number of embryos produced using this approach and reduce workload on the embryologist.

Indexed as

cytoplasmic fluidityfull‐term developmentintracytoplasmic sperm injectionoocyte survivalosmolality

Identifiers

PMID42253903
PMCPMC13240058

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.